DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Fundamental Analysis & Valuation

NASDAQ:DHCNI • US25525P2065

Current stock price

18.0001 USD
-0.41 (-2.23%)
Last:

This DHCNI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DHCNI Profitability Analysis

1.1 Basic Checks

  • In the past year DHCNI has reported negative net income.
  • DHCNI had a negative operating cash flow in the past year.
  • DHCNI had negative earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: DHCNI reported negative operating cash flow in multiple years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M

1.2 Ratios

  • DHCNI has a Return On Assets of -6.56%. This is amonst the worse of the industry: DHCNI underperforms 84.55% of its industry peers.
  • DHCNI has a worse Return On Equity (-17.16%) than 80.49% of its industry peers.
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROIC N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 -10 -15

1.3 Margins

  • Looking at the Gross Margin, with a value of 18.11%, DHCNI is doing worse than 92.68% of the companies in the same industry.
  • DHCNI's Gross Margin has declined in the last couple of years.
  • DHCNI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 18.11%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. DHCNI Health Analysis

2.1 Basic Checks

  • DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DHCNI has been increased compared to 1 year ago.
  • DHCNI has more shares outstanding than it did 5 years ago.
  • DHCNI has a better debt/assets ratio than last year.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • Based on the Altman-Z score of 0.38, we must say that DHCNI is in the distress zone and has some risk of bankruptcy.
  • DHCNI has a Altman-Z score of 0.38. This is comparable to the rest of the industry: DHCNI outperforms 46.34% of its industry peers.
  • DHCNI has a Debt/Equity ratio of 1.44. This is a high value indicating a heavy dependency on external financing.
  • DHCNI has a Debt to Equity ratio (1.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC8.6%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • DHCNI has a Current Ratio of 1.56. This is a normal value and indicates that DHCNI is financially healthy and should not expect problems in meeting its short term obligations.
  • With a decent Current ratio value of 1.56, DHCNI is doing good in the industry, outperforming 76.42% of the companies in the same industry.
  • DHCNI has a Quick Ratio of 1.56. This is a normal value and indicates that DHCNI is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of DHCNI (1.56) is better than 77.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DHCNI Growth Analysis

3.1 Past

  • The earnings per share for DHCNI have decreased by -4.76% in the last year.
  • The Revenue has been growing slightly by 2.84% in the past year.
  • Measured over the past years, DHCNI shows a decrease in Revenue. The Revenue has been decreasing by -1.18% on average per year.
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%

3.2 Future

  • Based on estimates for the next years, DHCNI will show a very strong growth in Earnings Per Share. The EPS will grow by 26.15% on average per year.
  • Based on estimates for the next years, DHCNI will show a small growth in Revenue. The Revenue will grow by 4.07% on average per year.
EPS Next Y50.42%
EPS Next 2Y26.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.21%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. DHCNI Valuation Analysis

4.1 Price/Earnings Ratio

  • DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

  • 89.43% of the companies in the same industry are cheaper than DHCNI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.98
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • DHCNI's earnings are expected to grow with 26.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.15%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. DHCNI Dividend Analysis

5.1 Amount

  • DHCNI has a yearly dividend return of 0.55%, which is pretty low.
  • Compared to an average industry Dividend Yield of 7.71, DHCNI's dividend is way lower than its industry peers. On top of this 90.24% of the companies listed in the same industry pay a better dividend than DHCNI!
  • Compared to an average S&P500 Dividend Yield of 1.82, DHCNI's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.55%

5.2 History

  • The dividend of DHCNI decreases each year by -25.96%.
  • DHCNI has been paying a dividend for over 5 years, so it has already some track record.
  • DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.96%
Div Incr Years0
Div Non Decr Years4
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • The earnings of DHCNI are negative and hence is the payout ratio. DHCNI will probably not be able to sustain this dividend level.
DP-3.38%
EPS Next 2Y26.15%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M -400M

More info and screens

Find the best dividend stocksShow peers with best dividend

DHCNI Fundamentals: All Metrics, Ratios and Statistics

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (4/16/2026, 4:30:02 PM)

18.0001

-0.41 (-2.23%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners79.63%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.36B
Revenue(TTM)1.54B
Net Income(TTM)-285.89M
Analysts74.29
Price Target18.38 (2.11%)
Short Float %0.02%
Short Ratio0.33
Dividend
Industry RankSector Rank
Dividend Yield 0.55%
Yearly Dividend0.04
Dividend Growth(5Y)-25.96%
DP-3.38%
Div Incr Years0
Div Non Decr Years4
Ex-Date04-15
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-82.03%
Min EPS beat(2)-213.15%
Max EPS beat(2)49.08%
EPS beat(4)2
Avg EPS beat(4)-28.15%
Min EPS beat(4)-213.15%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)-9.87%
EPS beat(12)5
Avg EPS beat(12)-4.94%
EPS beat(16)5
Avg EPS beat(16)-13.8%
Revenue beat(2)1
Avg Revenue beat(2)-1.84%
Min Revenue beat(2)-4.35%
Max Revenue beat(2)0.67%
Revenue beat(4)1
Avg Revenue beat(4)-1.05%
Min Revenue beat(4)-4.35%
Max Revenue beat(4)0.67%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)4
Avg Revenue beat(12)-0.74%
Revenue beat(16)5
Avg Revenue beat(16)-0.93%
PT rev (1m)9.53%
PT rev (3m)-5.45%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.45%
EPS NY rev (1m)1.82%
EPS NY rev (3m)6.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.49%
Revenue NY rev (1m)-1.31%
Revenue NY rev (3m)-2.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.83
P/FCF N/A
P/OCF N/A
P/B 2.62
P/tB 2.62
EV/EBITDA 28.98
EPS(TTM)-1.1
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-0.69
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.35
BVpS6.88
TBVpS6.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -6.56%
ROE -17.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 18.11%
FCFM N/A
ROA(3y)-6.38%
ROA(5y)-3.36%
ROE(3y)-16.21%
ROE(5y)-8.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.03%
GM growth 5Y-5.67%
F-Score6
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.44
Debt/FCF N/A
Debt/EBITDA 10.3
Cap/Depr 56.06%
Cap/Sales 9.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z 0.38
F-Score6
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)69.85%
Cap/Depr(5y)90%
Cap/Sales(3y)13.23%
Cap/Sales(5y)17.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y50.42%
EPS Next 2Y26.15%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.84%
Revenue growth 3Y6.21%
Revenue growth 5Y-1.18%
Sales Q2Q%-0.01%
Revenue Next Year1.21%
Revenue Next 2Y4.07%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y45.02%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1823.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-86.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-117.48%
OCF growth 3YN/A
OCF growth 5YN/A

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 / DHCNI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

ChartMill assigns a fundamental rating of 2 / 10 to DHCNI.


What is the valuation status of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) stock?

ChartMill assigns a valuation rating of 1 / 10 to DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI). This can be considered as Overvalued.


Can you provide the profitability details for DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42?

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for DHCNI stock?

The Earnings per Share (EPS) of DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) is expected to grow by 50.42% in the next year.